-
HIV Information: Author Paul Sax, M.D.

Paul E. Sax, MD

Paul E. Sax, MD is the Editor-in-Chief, Journal Watch HIV/AIDS Clinical Care, Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital, and Professor of Medicine at Harvard Medical School.

Learn more about HIV and ID Observations.

Posts Tagged ‘PI’

The 800-mg Darunavir Tablet Arrives, and Scoring the Top Protease Inhibitors

Paul Sax • November 18th, 2012

Categories: Health Care, HIV, Patient Care, Policy

(2 votes, average: 5.00 out of 5)

The FDA has approved an 800-mg tablet of darunavir for treatment naive patients. This single tablet will obviously replace the two darunavir 400-mg tablets in first-line therapy. (Yes, my math is that good.) Darunavir will still require 100-mg ritonavir boosting plus two NRTIs to make a complete regimen. Once upon a time I might have thought this [...]

Tags: , , , ,